Depression medications do work, but not as dramatically as most people expect. About 1 in 4 people who start a standard antidepressant will reach full remission on that first medication. After trying up to four different medications or combinations, roughly 35% to 41% achieve remission, depending on how strictly you measure it. That’s a real effect, but it’s far from a guarantee, and how well these drugs work depends heavily on how severe your depression is.
What the Numbers Actually Show
The largest real-world trial ever conducted on antidepressants, called STAR*D, followed over 3,000 patients through up to four rounds of treatment. The original investigators reported a 67% cumulative remission rate, a number that made its way into textbooks and prescribing conversations for years. But a rigorous reanalysis published in BMJ Open, using the study’s own original measurement criteria, found the true cumulative remission rate was closer to 35%.
Breaking that down by treatment round: about 25.5% of patients achieved remission on their first medication. For those who didn’t respond and tried a second, 21.3% reached remission. By the third attempt, that dropped to 13.2%, and by the fourth, just 10.4%. Each successive medication trial helps fewer people, but switching or adding medications does still help some.
Separately, a massive Lancet review of 522 trials covering 21 antidepressants confirmed that every single one outperformed placebo. The overall effect size was modest, with an average standardized difference of 0.30, meaning the drugs shifted symptoms in a real but moderate way across the full population studied.
Severity Makes a Big Difference
One of the most important and underappreciated findings in depression research is that antidepressants work best for people with the most severe symptoms. A patient-level meta-analysis published in JAMA found that for people with mild to moderate depression, the advantage of medication over a placebo was essentially negligible. The effect size in that group was 0.11, well below what’s considered clinically meaningful.
For people with severe depression, the benefit was still small. But for those with very severe depression, the picture changed dramatically: the effect size jumped to 0.47, and for the most severely affected patients it reached 0.81, which is considered a large treatment effect. In practical terms, this means someone who is deeply, functionally impaired by depression is far more likely to notice a meaningful difference from medication than someone with milder symptoms.
This doesn’t mean antidepressants are useless for moderate depression. The placebo response in those trials was substantial, meaning many people improved regardless of whether they got the real drug. But the specific chemical effect of the medication, the part that goes beyond simply believing you’re being treated, becomes clearly measurable only as symptoms get more severe.
How These Medications Work in the Brain
Most commonly prescribed antidepressants increase the availability of chemical messengers in the brain. The most popular class, SSRIs, blocks the brain from reabsorbing serotonin, leaving more of it active between nerve cells. SNRIs do the same for both serotonin and norepinephrine, a second messenger involved in energy and alertness. A third type blocks the reabsorption of norepinephrine and dopamine, which plays a role in motivation and reward.
Newer medications take different approaches entirely. One targets the brain’s glutamate system, which controls how nerve cells communicate and adapt. This drug, a nasal spray derived from ketamine, can produce noticeable effects within hours rather than weeks. It’s approved specifically for people whose depression hasn’t responded to standard medications.
How Long They Take to Kick In
Standard antidepressants are slow. The traditional expectation has been that a reliable response takes two to three weeks, and research supports an average onset of about 13 days for initial improvement. Full response criteria typically take around 20 days to meet. Some patients notice subtle changes within the first week, but this varies widely.
This delay matters because it means you can’t tell from the first few days whether a medication is going to work for you. Most prescribers recommend giving a new antidepressant at least four to six weeks before concluding it isn’t helping. That waiting period, especially when you’re already struggling, is one of the most frustrating aspects of treatment.
The exceptions are rare. Ketamine-based treatments can produce antidepressant effects within two hours of a single dose, with 71% of treatment-resistant patients in one study showing significant improvement within 24 hours that lasted over a week. But these are specialized treatments, not first-line options.
Side Effects Are Common
A multicenter study of patients on antidepressants found that 64% reported weight gain, 51% experienced nausea and vomiting, 49% had dry mouth, and 41% reported headaches. Sexual dysfunction and fatigue are also frequent, and these side effects are among the top reasons people stop taking their medication.
Side effects often emerge before the therapeutic benefits do, which creates a difficult early window where you feel worse in new ways without yet feeling better in the ways you hoped. Many side effects lessen after the first few weeks as your body adjusts, but some, particularly weight gain and sexual side effects, can persist for as long as you take the medication.
When Depression Doesn’t Respond
At least 30% of people with depression meet the formal definition of treatment-resistant depression, meaning they haven’t improved adequately after trying two or more medications at proper doses for adequate lengths of time. Some estimates place the figure closer to 55% when using stricter criteria for what counts as a good response. This is not a small or unusual outcome.
For people in this group, options include combining medications, adding a non-antidepressant medication to boost effectiveness, or turning to newer treatments like ketamine-based therapy. Psychotherapy, particularly cognitive behavioral therapy, works through different mechanisms than medication and can be effective alone or in combination with drugs.
Staying on Medication After Recovery
One area where the evidence for antidepressants is unambiguous is relapse prevention. A systematic review of 31 randomized trials found that people who continued their antidepressant after recovering had an 18% relapse rate, compared to 41% among those who stopped. That’s a 70% reduction in the odds of relapsing.
This is why most guidelines recommend staying on medication for at least six to twelve months after symptoms resolve, and longer for people who have had multiple depressive episodes. Stopping too early is one of the most common reasons depression comes back, and tapering off should always be gradual to avoid withdrawal-like discontinuation symptoms.
The Honest Bottom Line
Antidepressants are genuinely effective, but they’re not as effective as many people assume going in. They work best for severe depression, take weeks to show results, cause side effects in the majority of users, and leave a large percentage of people still searching for something that works. For the people they do help, though, the benefit can be substantial, and staying on them after recovery significantly reduces the chance of falling back into depression.